Stock JAN JANONE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials JanOne Inc.

Equities

JAN

US47089W1045

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
4.3 USD -0.46% Intraday chart for JanOne Inc. +21.13% +674.77%
Apr. 18 JanOne Files Prospectus for $100 Million Mixed Shelf Offering MT
Apr. 15 North American Morning Briefing : Stock Futures -2- DJ

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4.279 5.504 9.955 11.62 4.316 2.751
Enterprise Value (EV) 1 3.34 9.705 16.2 17.56 16.34 3.167
P/E ratio -0.67 x -0.42 x -1.19 x -0.65 x 0.39 x -0.28 x
Yield - - - - - -
Capitalization / Revenue 0.12 x 0.16 x 0.29 x 0.29 x 0.11 x -
EV / Revenue 0.09 x 0.28 x 0.48 x 0.44 x 0.41 x -
EV / EBITDA -1.59 x -1.16 x -3.32 x -6.28 x -4.52 x -0.96 x
EV / FCF 0.33 x -151 x 11.8 x -14.6 x -3.11 x -0.3 x
FCF Yield 306% -0.66% 8.45% -6.83% -32.2% -331%
Price to Book 0.2 x 0.53 x 4.21 x -1.34 x 1.87 x -0.83 x
Nbr of stocks (in thousands) 1,695 1,918 1,830 2,827 3,150 4,958
Reference price 2 2.525 2.870 5.440 4.110 1.370 0.5550
Announcement Date 3/29/19 4/6/20 3/30/21 4/1/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 36.79 35.1 33.87 40.02 39.61 -
EBITDA 1 -2.099 -8.355 -4.874 -2.797 -3.616 -3.294
EBIT 1 -6.097 -12.43 -8.996 -6.989 -4.171 -4.746
Operating Margin -16.57% -35.42% -26.56% -17.46% -10.53% -
Earnings before Tax (EBT) 1 -6.335 -15.16 -8.925 -16.61 -3.082 -17.52
Net income 1 -5.608 -11.96 -8.498 -16.89 10.99 -7.812
Net margin -15.24% -34.09% -25.09% -42.19% 27.75% -
EPS 2 -3.751 -6.784 -4.590 -6.352 3.489 -1.952
Free Cash Flow 1 10.22 -0.0644 1.368 -1.199 -5.256 -10.49
FCF margin 27.77% -0.18% 4.04% -3% -13.27% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 4/6/20 3/30/21 4/1/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 4.2 6.25 5.94 12 0.42
Net Cash position 1 0.94 - - - - -
Leverage (Debt/EBITDA) - -0.5028 x -1.282 x -2.122 x -3.325 x -0.1263 x
Free Cash Flow 1 10.2 -0.06 1.37 -1.2 -5.26 -10.5
ROE (net income / shareholders' equity) -23.4% -74.9% -134% 535% 88.2% -122%
ROA (Net income/ Total Assets) -9.35% -24.3% -21.1% -22.1% -8.42% -9.09%
Assets 1 59.98 49.33 40.34 76.38 -130.5 85.91
Book Value Per Share 2 12.80 5.390 1.290 -3.070 0.7300 -0.6700
Cash Flow per Share 2 0.7100 0.2500 0.2100 0.2500 0.0400 0
Capex 1 0.4 0.21 0.51 1.66 0.81 -
Capex / Sales 1.09% 0.6% 1.5% 4.15% 2.04% -
Announcement Date 3/29/19 4/6/20 3/30/21 4/1/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
JANONE INC. Stock JanOne Inc.
+674.77% 37.3M
MODERNA, INC. Stock Moderna, Inc.
+22.56% 46.71B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.51% 41.52B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.8B
CELLTRION, INC. Stock Celltrion, Inc.
-3.42% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.13% 25.78B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.44% 19.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.45% 11.98B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.14% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.47% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. JAN Stock
  4. Financials JanOne Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW